Fig. 1: Southern blot of genomic DNA from normal tissue (N) and from a tumour (T) from patients with breast cancer. The first and second lanes are from an informative patient with no LOH (since the two bands are conserved), whereas the remaining lanes are from two noninformative patients, each having one of the two possible restriction fragment length polymorphisms after Taq1 digestion.